Description
CX-6258 is an inhibitor of Pim kinase that exhibits anticancer chemotherapeutic activity. This compound decreases tumor growth in animal models of cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
CX-6258 is an inhibitor of Pim kinase that exhibits anticancer chemotherapeutic activity. This compound decreases tumor growth in animal models of cancer.
| Cas No. | 1202916-90-2 |
|---|---|
| Purity | ≥98% |
| Formula | C26H24ClN3O3 |
| Formula Wt. | 461.95 |
| IUPAC Name | (3E)-5-Chloro-3-[(5-{3-[(4-methyl-1,4-diazepan-1-yl)carbonyl]phenyl}-2-furyl)methylene]-1,3-dihydro-2H-indol-2-one |
| Solubility | Water 89 mg/mL warmed (178.57 mM) DMSO 57 mg/mL warmed (114.36 mM) Ethanol 1 mg/mL warmed (2.0 mM) |
| Appearance | Light yellow solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Padmanabhan A, Gosc EB, Bieberich CJ. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells. J Cell Biochem. 2013 May;114(5):1050-7. PMID: 23129228.
Haddach M, Michaux J, Schwaebe MK, et al. Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. ACS Med Chem Lett. 2011 Dec 27;3(2):135-9. PMID: 24900437.
Peptide, involved in feeding behavior and insul...
c-MET inhibitor.
Carotenoid found in shrimp, salmon, and algae.<...
Tamoxifen analog; SERM.
Diterpene lactone found in Ginkgo; GABA-A, α-1...
Glycoside hydroquinone originally found in Berg...
PLK4 inhibitor.
HDAC inhibitor.
p110β PI3K inhibitor.
Histamine H2 antagonist.
Indoleamine-2,3-dioxygenase inhibitor.
5-Nitroimidazole derivative; genotoxic.
Endogenous peptide, connects A and B chains of ...
NMDA potentiator, GABA-A antagonist.
β-lactam cephalosporin; penicillin binding pro...
Nucleotide (guanine) analog, prevents guanine s...
Neuroactive mycotoxin produced by Penicillum an...
Dihydrofolate reductase inhibitor.
GRP analog, found in Bombina; bombesin and GRP ...
Imidazole; 14-α demethylase inhibitor, potenti...